Robert M. Centor, MD; Joel M. Topf, MD
Disclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. Topf has disclosed the following: Consultantship: Davita; Other: Davita (joint venture; small ownership of multiple dialysis units and a vascular access center).
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Proctor & Gamble, Pfizer, and Johnson & Johnson.
Audio. Annals On Call - Diuretic Resistance: Dr. Centor discusses diuretic resistance in patients with heart failure with Dr. Joel Topf. Listeners will gain knowledge to help make better-informed choices when prescribing diuretics to patients with heart failure.
Other Audio Options: Download MP3
Centor RM, Topf JM. Annals On Call - Diuretic Resistance. Ann Intern Med. 2018;169:OC1. doi: https://doi.org/10.7326/A18-0006
Download citation file:
Published: Ann Intern Med. 2018;169(8):OC1.
Cardiology, Heart Failure.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use